Roche's Covid antibody cocktail launched in India for treatment of mild to moderate cases
India | May 24, 2021 15:59 ISTRoche's Antibody Cocktail is now available in India at Rs 59,750 per dose for the treatment of mild to moderate Covid patients.
Roche's Antibody Cocktail is now available in India at Rs 59,750 per dose for the treatment of mild to moderate Covid patients.
Tamil Nadu reported 35,483 new COVID cases and 422 deaths - a decline seen for the second day on Sunday. With this tally, caseload is 18,42,344 and the death toll 20,468 till date.
Mandira Bedi, popular actress and fitness enthusiast, talks about keeping yourself mentally and physically fit during these tough times, On India TV's #JeetegaIndiaHaaregaCorona, Bedi shares that making exercise and fitness a part of the lifestyle helps everyone attain a better life.
Two doses of the Oxford/AstraZeneca vaccine have shown to prevent around 85 to 90 per cent of symptomatic COVID-19 infections, the first real-world data from Public Health England (PHE) has found.
The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%.
How to use CoviSelf: The ICMR has approved a home-based rapid antigen testing (RAT) kit. The kit should be used only on symptomatic individuals.
BJP president JP Nadda said that coronavirus vaccine will be available for all in the country by December.
Birla, the MP from Kota- a major coaching hub for competitive examination preparations in the country- held a meeting with the directors of coaching institutes in the city and requested them to come forward to help the needy in these challenging times, his office said in a statement.
Health officials said that more than 36,000 people in the rural areas will be been covered by these teams which have been deployed by the district health department.
The national capital Wednesday reported 3,846 cases, the lowest since April 5, and 235 fatalities while the positivity rate dipped to 5.78 per cent, according to the latest health bulletin released by the Delhi government. This is the third day on the trot that the number of cases has remained below 5,000.
Alerts have been raised in some countries on post-vaccination "embolic and thrombotic events" on 11 March, 2021 particularly with AstraZeneca-Oxford vaccine (Covishield in India).
The first batch of 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 was released by Defence Minister Rajnath Singh on Monday. The medicine is being touted as a game-changer in the fight against COVID.
Sputnik V Light, Russia's single-dose vaccine for Covid19 is expected to be launched in India soon, informed Russia Direct Investment Fund CEO Kirill Dmitriev on Friday.
The government on Tuesday said that an early trend of decline in daily new COVID-19 cases and deaths has been noted in the country.
The total recoveries in a span of 24 hours too outnumbered the daily new COVID-19 cases after 61 days. The total active cases now comprise 16.16 per cent of the country's total coronavirus infections.
The Uttar Pradesh government on Monday organised a Covid-19 vaccination camp for media officials in Noida that houses the editorial headquarters of multiple media organisation
Based on these results, the DCGI's Central Drugs Standard Control Organisation (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020. The ministry said the DRDO, along with DRL started the clinical trials to test the safety and efficacy of the drug in COVID-19 patients.
The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories in Hyderabad.
Since April, Navi Mumbai Municipal Corporation had been using the building to house doctors and health workers engaged in the battle against COVID.
The Delhi govt has decided to organise a mass COVID-19 vaccination drive for all the Media houses. The govt will organise vaccination drive at their offices and bear the cost.
Top News
Latest News
